Prevalence of Multidrug and extensively drug-resistant tuberculosis in Beijing, china: A hospital-based retrospective study

Japanese Journal of Infectious Diseases

Volumn 63, Issue 5, 2010, Pages 368-371

  Wang, Di ^a   Yang, Caie ^a   Kuang, Tieji ^a   Lei, Hong ^a   Meng, Xianghong ^a   Tong, Aihua ^a   He, Jufang ^a   Jiang, Ying ^a   Guo, Fengjie ^a   Dong, Mei ^a  

^a 309TH HOSPITAL OF PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; HEALTH SURVEY; HOSPITAL; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY;

ANTITUBERCULAR AGENTS; CHINA; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 77957726864     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. World Health Organization (2007): Global tuberculosis control-surveillance, planning, financing. World Health Organization, Geneva, Switzerland.
2. World Health Organization (2009): Global tuberculosis control-a short update to the 2009 report. World Health Organization, Geneva, Switzerland.
3. World Health Organization (2008): Anti-tuberculosis drug resistance in the world. In report no. 4. World Health Organization, Geneva, Switzerland.
4. Centers for Disease Control and Prevention (2006): Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000-2004. Morb. Mortal. Wkly. Rep., 55, 301-305.
5. Leimane, V., Riekstina, V., Holtz, T.H., et al. (2005): Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet, 365, 318-326.
6. He, G.X., Zhao, Y.L., Jiang, G.L., et al. (2008): Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect. Dis., 8, 166.
7. Hu, Y., Mathema, B., Wang, W., et al. (2008): Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China. Microb. Drug Resist., 14, 227-232.
8. Xu, P., Li, X., Zhao, M., et al. (2009): Prevalence of fluoro-quinolone resistance among tuberculosis patients in Shanghai, China. Antimicrob. Agents Chemother., 53, 3170-3172.
9. Sugawara, I., Otomo, K., Yamada, H., et al. (2005): The molecular epidemiology of ethambutol-resistant Mycobacterium tuberculosis in Henan Province, China. Jpn. J. Infect. Dis., 58, 393-395.
10. Canetti, G., Fox, W., Khomenko, A., et al. (1969): Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull. World Health Organ., 41, 21-43.
11. Kuang, T., Song, P., Wang, L., et al. (1995): The study on the simplified agar media for mycobacteria. Wei Sheng Wu Xue Bao, 35, 298-302 (in Chinese).
12. World Health Organization (2001): Guidelines for drug susceptibility testing for second line anti-tuberculosis drugs for DOTs plus. World Health Organization, Geneva, Switzerland.
13. Kam, K.M. and Yip, C.W. (2004): Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus. Int. J. Tuberc. Lung Dis., 8, 760-766.
14. Zhao, M., Li, X., Xu, P., et al. (2009): Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS One, 4, e4370.
15. World Health Organization (2006): Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly. Epidemiol. Rec., 81, 430-432.
16. American Academy of Family Physician (1993): CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era. Am. Fam. Physician, 48, 671-672.
17. Migliori, G.B., Lange, C., Girardi, E., et al. (2008): Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. Clin. Infect. Dis., 46, 958-959.